Suppression of rat carotid lesion development by the calcium channel blocker PN 200-110

American Journal of Pathology

Volumn 124, Issue 1, 1986, Pages 88-93

  Handley, D A ^a   Van Valen, R G ^a   Melden, M K ^a   Saunders, R N ^a  

^a Sandoz Pharma Ltd   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ANTAGONIST; DARODIPINE; ISRADIPINE; PN 200 100; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTERY INTIMA PROLIFERATION; BIOLOGICAL MODEL; BLOOD AND HEMOPOIETIC SYSTEM; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CAROTID ARTERY; DRUG COMPARISON; DRUG MECHANISM; ETIOLOGY; GREAT BLOOD VESSEL; HISTOLOGY; NONHUMAN; PERIPHERAL VASCULAR SYSTEM; PREVENTION; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE;

ANGIOPLASTY, BALLOON; ANIMAL; ARTERIOSCLEROSIS; BLOOD PLATELETS; BLOOD PRESSURE; CAROTID ARTERIES; HYPOTENSION; ISRADIPINE; MALE; MUSCLE, SMOOTH, VASCULAR; NIFEDIPINE; OXADIAZOLES; RATS; RATS, INBRED STRAINS;

EID: 0022493375     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)